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Nonsyndromic cleft lip with or without cleft palate (NSCLP) is a common birth anomaly that requires
prolonged multidisciplinary rehabilitation. Although variation in several genes has been identified as
contributing to NSCLP, most of the genetic susceptibility loci have yet to be defined. To identify additional
contributory genes, a high-throughput genomic scan was performed using the Illumina Linkage IVb Panel
platform. We genotyped 6008 SNPs in nine non-Hispanic white NSCLP multiplex families and a single large
African-American NSCLP multiplex family. Fourteen chromosomal regions were identified with LOD41.5,
including six regions not previously reported. Analysis of the data from the African-American and non-
Hispanic white families revealed two likely chromosomal regions: 8q21.3–24.12 and 22q12.2–12.3 with
LOD scores of 2.98 and 2.66, respectively. On the basis of biological function, syndecan 2 (SDC2) and
growth differentiation factor 6 (GDF6) in 8q21.3–24.12 and myosin heavy-chain 9, non-muscle (MYH9) in
22q12.2–12.3 were selected as candidate genes. Association analyses from these genes yielded marginally
significant P-values for SNPs in SDC2 and GDF6 (0.01rPo0.05). Evidence for an altered transmission was
found for four MYH9 SNPs (Po0.01). SNP rs1002246 exhibited altered transmission by all analytic
methods. However, analysis of two SNP MYH9 haplotypes did not identify a single high-risk haplotype. Our
results confirm a previous report that 8q21.3–24.12 may harbor a clefting gene and identify 22q12.2–12.3
as a new candidate region that contains MYH9. Most importantly, we confirm the previous report of an
association with MYH9.
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Introduction
Nonsyndromic cleft lip with or without cleft palate
(NSCLP) is a common congenital anomaly with a pre-
valence of 1/500–1/1400 live births and varies with
ethnicity.1 – 3 Non-Hispanic white and Hispanic popula-
tions have a higher prevalence than African-American
populations but a lower prevalence than Asian popula-
tions.1,3,4 NSCLP is considered to be a multifactorial
disorder, that is, caused by both genes and environmental
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exposures, neither of which has been fully defined. Any-
where from 2 to 14 genes have been proposed to contribute
to the NSCLP phenotype and association and linkage
studies have identified some of these putative genes.5 – 7
Genome scans have proven to be a useful tool for
identifying NSCLP candidate chromosomal regions. Seven
NSCLP genome scans have been reported involving
populations from East Asia, India, Europe, Syria and
Turkey.8 – 14 In addition, a meta-analysis was performed
on data generated from 13 NSCLP studies, including 5 of
the aforementioned studies and 8 additional unpublished
data sets.15 The individual genomic scans have identified
3–20 candidate regions (Supplementary Table 1), and
1p31–36, 2q32–37, 6q21–27 and 16q21–24 were com-
mon to at least four of the eight studies listed in
Supplementary Table 1.8 – 15
To confirm previously reported chromosomal regions
and to identify new chromosomal regions likely to contain
NSCLP genes, we subjected 10 multiplex NSCLP families to
genomic screening utilizing the Illumina Linkage IVb 6K
SNP Linkage Panel (Illumina Inc., San Diego, CA, USA). Of
these, nine families are from our well-characterized non-
Hispanic white data set and one family was African
American. We identified one new region from each ethnic
group with an LOD 42.5; one from chromosome 8q21.3–
24.12 (2.98; African American) and one from chromosome
22q12.2–q12.3 (2.66; non-Hispanic white). Two candidate
genes from the chromosome 8 region and one from the
chromosome 22 region were further evaluated.
Inspection of the region(s) with the highest LOD score
from each ethnic group identified three genes of interest:
growth differentiation factor 6 (GDF6) and syndecan 2
(SDC2) in 8q21.3–24.12 and myosin heavy chain 9 (MYH9)
in 22q12.2–12.3.16 SDC2 and GDF6 on chromosome 8
were considered to be good candidate genes because of
their known biological function. SDC2 is involved in cell
signaling, migration and cell–matrix interactions and
interacts with members of the transforming growth
factor-b family.17 – 19 GDF6 is a member of the bone
morphogenetic protein group that forms part of the
transforming growth factor-b superfamily and is expressed
in the craniofacial region during embryogenesis20 – 24
MYH9 on chromosome 22 is of particular interest because
it is highly expressed in the palatal shelves before fusion.25
Moreover, in a recent study of NSCLP in a group of Italians,
an association was identified with an SNP in MYH9.26 In
this study, we identified SNPs spanning the candidate
genes and evaluated them for evidence and/or association.
Materials and methods
Data set
The data set consists of 123 families with a history of
NSCLP. Of these, there are 81 extended multiplex families
(65 non-Hispanic white, 15 Hispanic and 1 African
American) and 42 multiplex trios/duos (23 non-Hispanic
white and 19 Hispanic) with a positive history of NSCLP. In
addition, there are 316 simplex trios/duos (226 non-
Hispanic white, 82 Hispanic and 8 African American) with
no family history of NSCLP. These families, methods of
ascertainment and inclusion criteria have been reported
earlier.27 Blood or saliva samples were collected after
obtaining informed consent. DNA was extracted from
blood using Roche DNA Isolation Kit for Mammalian
Blood (Roche, Basel, Switzerland) or from saliva using
Oragene Purifier (DNA Genotek Inc., Ottawa, ON, Canada)
following the manufacturer’s protocol.
Genome scan
Ten multiplex families were subjected to a genome scan
using the 6 K Illumina Linkage IVb mapping panel. These
families were selected from our data set on the basis of the
number of affected individuals and availability of DNA.
Nine families were non-Hispanic white and one (F1100)
was African American (Figure 1). Under our dominant
model, four of the non-Hispanic white families, 100, 1000,
1200 and 3000, can yield maximum LOD scores greater
than 1 (1.6, 1.5, 1.1 and 1.2, respectively). A maximum
LOD score of 2.98 is possible for the African-American
family. Among the non-Hispanic white families, there were
30 affected individuals of 67 individuals. In family 100
(F100), there were two siblings (III-4 and III-9) who were
reported to have a notched gum in childhood, a finding
that could indicate a microform cleft lip. However, these
diagnoses could not be clinically confirmed. Therefore, the
linkage analysis was performed twice: first, assuming these
individuals to be affected and then coding them as
unknown with regard to the cleft phenotype. There were
27 genotyped individuals in the African-American family, 7
of whom were affected.
The Illumina Linkage IVb mapping panel consisting of
six 008 SNPs was used on a BeadStation system (Illumina
Inc.). Allele detection and genotype calling were performed
using the BeadStudio software (Illumina Inc.).
Candidate genes
Thirty-seven SNPs spanning the three candidate genes
identified in the genome scan (GDF6 – 6; SDC2 – 21; and
MYH9 – 10) were subsequently typed in the entire NSCLP
data set with the exclusion of the African-American
families; selection criteria for these SNPs were discussed
earlier.27 GDF6 and SDC2 SNPs were chosen with minor
allele frequency 40.3, preferentially selecting coding and
TagSNPs to obtain maximum coverage of these genes. Six
of the MYH9 SNPs were chosen on the basis of a previous
publication;26 the remaining four SNPs in the MYH9 gene
were selected using the above criteria. TaqMan Assays
(Applied Biosystems; Foster City, CA, USA) were used for
genotyping; alleles were detected using the ABI 7900HT
Sequence Detection System. All genotyping results were
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imported into Progeny Lab (South Bend, Indiana, USA),
and PedCheck was run on all SNPs to identify Mendelian
inconsistencies.28
Analysis
Results of genotyping from the genome scan were
subjected to parametric and non-parametric linkage ana-
lyses using MERLIN.29 Linkage parameters were as pre-
viously calculated, that is, dominant model with
penetrances of 0.24 in females and 0.32 in males and a
phenocopy rate of 0.001.30 An r2 of 0.19 was the cutoff
value for clustering SNPs to remove the effect of linkage
disequilibrium. Family 1100 was analyzed separately
because of its different race/ethnicity. Analysis of the
candidate gene SNPs was restricted to our Hispanic and
non-Hispanic white families, as the number of families of
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Figure 1 Families included in genome scan. Family 1100 is African American; all the remaining families are non-Hispanic white. *DNA included in
the genome scan; arrow denotes proband. Filled symbols denote affected individuals; half-filled symbols denote notched gum; empty symbols denote
unaffected individual.
NSCLP genome scan and MYH9
BT Chiquet et al
197
European Journal of Human Genetics
other ethnicities was small. For analyses of the candidate
gene SNPs, probands/families were stratified by ethnicity
alone or by ethnicity and family history. In addition, the
Hispanic and non-Hispanic white families were analyzed
together for the MYH9 SNPs, as the allele frequencies and
LD patterns did not differ between the two ethnicities.
Allele frequencies and the Hardy–Weinberg equilibrium
(HWE) were calculated using SAS (v9.1). Pairwise linkage
disequilibrium values (D0 and r2) were calculated using
GOLD.31 To extract the maximum amount of information
from the data set, multiple approaches for assessing linkage
and/or association were used. Parametric and non-
parametric linkage analyses were performed as discussed
above. The pedigree disequilibrium test (PDT), Geno-PDT
(G-PDT) and association in the presence of linkage (APL)
test were used to evaluate evidence for association.32 – 34
This panel of analytic tools was chosen because each has
different strengths and assumptions. PDT is an extension
of the transmission disequilibrium test and allows for the
incorporation of extended pedigrees in the analysis of
allelic association. The G-PDT examines the association
between marker genotypes and disease, whereas APL allows
for missing parental genotypes. Each program may be more
powerful for certain genetic models and for different
pedigree structures. In addition, APL can be used to
examine multi-marker haplotypes; it was used to look for
the overtransmission of two-marker haplotypes within
genes; all possible pairwise combinations of SNPs were
included.
Results
Genome scan
Ten families were subjected to the Illumina Linkage IVb
SNP genome-wide panel. Nine non-Hispanic white families
generated 11 chromosomal regions with an LOD 41.5
with parametric and/or non-parametric analysis (Table 1).
The highest LOD score for either methodology was two
SNPs in the chromosome 22q12.2–q12.3 region (rs762883
and rs9862). Three of the families, 100, 1000 and 3000,
had maximum LOD score 41.0 in the region (1.05, 1.11
and 1.12, respectively), although not for the same set
of SNPs (data not shown). Three chromosomal regions
with an LOD 41.5 were identified in the large African-
American family (Table 2). The highest LOD score
(2.98) was found in an SNP in chromosome 8q21.3–
24.12. This is the maximum possible LOD score for this
family. There was no overlap in the regions identified in
these two groups. The multipoint graphs for chromosomes
with LOD scores 41.5 are shown in Supplementary
Figures 2 and 3.
Candidate genes
All 37 SNPs from the three candidate genes, MYH9, GDF6
and SDC2, were in HWE. The allele frequencies of most
SNPs in GDF6 and SDC2 were significantly different
between the non-Hispanic whites and Hispanics, even
after Bonferroni correction (P¼0.001) (Table 3A). There-
fore, the data were stratified by ethnicity for the analysis of
these genes. In contrast, the differences in the MYH9 SNPs
did not meet this criterion (Table 3B). For this reason,
MYH9 SNPs were analyzed with the two ethnicities
combined.
Two-point parametric and non-parametric analyses in
the combined data set found evidence for linkage to a
single SNP, rs1002246, in MYH9 (HLOD¼1.58 and
P¼0.0006, respectively) (Table 4). There was no evidence
for linkage by multipoint analysis (data not shown).
However, all three methods of association analysis identi-
fied evidence for altered transmission of this same SNP,
rs1002246 (Table 5). In addition, PDT detected evidence for
an altered transmission of three additional SNPs. When the
data were stratified by family history, a marginally
significant association was still present for the SNP,
Table 1 Chromosomal regions with LOD 41.5 in nine non-Hispanic white families
Maximum LOD score
Parametric (hLOD) Non-parametric (LOD)
Chromosome Region a dbSNP cM Aff b Unk c Aff b Unk c
3 3p23 rs342758 58.08 0.35 0.85 0.92 1.64
3 3p21.1 rs11235 71.53 0.87 1.58 0.49 1.03
3 3p13–14.1a rs736333 94.05 0.24 0.67 0.65 1.53
5 5p13.3a rs1966983 51.74 0.94 1.64 0.72 1.19
5 5q35.2 rs1875189 192.51 0.57 0.53 1.59 1.04
6 6q27 rs727811 177.17 0.85 1.66 0.28 0.45
7 7q36.2–36.3a rs7795368 182.8 1.7 2.59 0.57 1.16
9 9q22.2–22.32a rs1048510 97.53 1.78 1.27 0.96 0.82
9 9q33.2–33.3 rs1984001 132.41 1.46 0.95 1.87 1.73
22 22q11.23–12.1 rs763281 21.41 1.75 1.22 1.46 0.99
22 22q12.2–12.3a rs762883 36.94 2.66 2.12 2.49 2.17
aNovel region identified.
bAff, Analysis of F100 individuals with notched gums classified as affected.
cUnk, Analysis of F100 individuals with notched gums classified as unknown.
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rs1002246, in the simplex data set (P¼0.03). Inspection of
all two-SNP haplotypes found that most haplotypes
constructed with rs1002246 and containing the ‘A’ allele
were overtransmitted, but generally did not reach signifi-
cance, even when stratified by ethnicity and/or family
history (data not shown). The minor allele frequency (ie,
frequency of the ‘A’ allele) was 0.34 in the non-Hispanic
whites. Haplotypes with the ‘G’ rs1002246 allele were
either undertransmitted or demonstrated the expected
transmission.
There was no evidence for linkage to SNPs in SDC2.
Marginal significance for altered transmission was detected
in both the non-Hispanic white and Hispanic samples
(Table 6A and B and Supplementary Tables 2 and 3). In
the simplex non-Hispanic white sample, rs1042381
was marginally significant (Table 6A). In the Hispanic
sample, significant association was detected in the entire
data set for rs198456, in the multiplex families for
rs2437772 and rs2437780, and for the simplex families
for rs2582831 and rs2582846 (Table 6B). Two SDC2
haplotypes demonstrated excess transmission in the non-
Hispanic white group and three in the Hispanic group
(Table 7).
No evidence for linkage to SNPs in GDF6 was detected.
Again, altered transmission was only marginally significant
for two SNPs: rs2255182 in the complete non-Hispanic
white sample and both the multiplex and simplex
subgroups (P¼0.04, P¼0.02 and P¼0.04, respectively)
and rs2247792 in the non-Hispanic white multiplex
families (P¼0.03) (Table 6A). Overtransmission of one
haplotype involving rs24401199 and rs2514527 was
observed in the Hispanic sample (P¼0.008) (Table 7).
Discussion
This study was undertaken to identify additional genes that
contribute to the NSCLP phenotype. One African-Amer-
ican and nine non-Hispanic white families were analyzed
by a 6 K genome scan. Fourteen regions were identified
with LOD scores 41.5 and four regions had LOD scores 42
(2p22, 7q36.2–36.3, 8q21.3–24.12 and 22q12.1-q12.3)
(Tables 1 and 2). Of these, only the 8q21.3–24.12 region
had previously been identified by genomic scanning
(Supplementary Table 1).11,15 The region from each
Table 2 Chromosomal regions with LOD41.5 in the African-American family
Maximum LOD score
Chromosome Regiona dbSNP cM Parametric (hLOD) Non-parametric (LOD)
2 2p22a rs1446297 62.97 2.27 1.07
3 3p26 rs11130180 15.16 2 0.71
8 8q21.3–24.12 rs536161 97.66 2.98 1.47
aIndicates novel region identified.
Table 3A Allele frequencies of chromosome 8 dbSNPs
Gene dbSNPa Base pair Location MAFb HCFc,d
SDC2 rs2452993 97 574 572 Upstream 0.42 0.59***
SDC2 rs2437772 97 582 153 Intron 1 0.31 0.27
SDC2 rs2437780 97 588 852 Intron 1 0.30 0.26
SDC2 rs2575738 97 599 578 Intron 1 0.29 0.20*
SDC2 rs7003874 97 607 128 Intron 1 0.46 0.35*
SDC2 rs874643 97 611 319 Intron 1 0.19 0.40***
SDC2 rs2440681 97 613 757 Intron 1 0.35 0.22***
SDC2 rs2582831 97 620 954 Intron 1 0.28 0.44***
SDC2 rs2582839 97 627 443 Intron 1 0.29 0.46***
SDC2 rs1444573 97 633 837 Intron 1 0.37 0.58***
SDC2 rs1984456 97 636 282 Intron 1 0.35 0.48***
SDC2 rs2582846 97 642 858 Intron 1 0.20 0.43***
SDC2 rs12156240 97 646 383 Intron 1 0.49 0.69***
SDC2 rs2575702 97 654 007 Intron 1 0.34 0.46**
SDC2 rs2651472 97 665 849 Intron 1 0.49 0.58*
SDC2 rs2028086 97 673 354 Intron 1 0.24 0.14**
SDC2 rs1836910 97 680 704 Intron 2 0.26 0.17*
SDC2 rs1042381 97 683 837 Exon 3 0.18 0.14
SDC2 rs2651454 97 690 146 Intron 4 0.23 0.38***
SDC2 rs2651458 97 694 626 Downstream 0.23 0.38***
SDC2 rs714046 97 700 749 Downstream 0.19 0.2
GDF6 rs2247792 97 219 221 Upstream 0.41 0.21***
GDF6 rs2440199 97 225 587 Exon 1 0.41 0.63***
GDF6 rs2255182 97 234 080 Intron 1 0.49 0.28***
GDF6 rs2514527 97 238 503 Intron 1 0.38 0.64***
GDF6 rs2514531 97 243 999 Downstream 0.45 0.26***
GDF6 rs714552 97 252 618 Downstream 0.40 0.61***
aBold dbSNPs are also genotyped in genome scan.
bMinor allele frequency of non-Hispanic white data set.
cCorresponding frequency in Hispanic of non-Hispanic white minor
allele.
dP-value less than *0.05, **0.001 and ***0.0001.
Table 3B Allele frequencies of chromosome 22 dbSNPs
Gene dbSNP Base pair Location MAFa HCFb,c
MYH9 rs7078 35 007 860 Downstream 0.30 0.25
MYH9 rs4821478 35 020 059 Intron 28 0.35 0.35
MYH9 rs2009930 35 029 252 Intron 19 0.35 0.37
MYH9 rs2239783 35 035 074 Intron 15 0.26 0.27
MYH9 rs3752462 35 040 129 Intron 13 0.36 0.37
MYH9 rs1002246 35 044 605 Intron 10 0.34 0.33
MYH9 rs2071731 35 048 804 Intron 5 0.37 0.34
MYH9 rs713659 35 058 638 Intron 3 0.42 0.37
MYH9 rs713839 35 063 884 Intron 3 0.38 0.35
MYH9 rs739097 35 076 025 Intron 1 0.44 0.36
aMinor allele frequency of non-Hispanic white data set.
bCorresponding frequency in Hispanic of non-Hispanic white minor
allele.
cP-value less than *0.05, **0.001 and ***0.0001.
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Table 5 Results for MYH9 from current and previously reported study
Martinelli et al Current dataa
Italian sample Entire sample Multiplex families Simplex families
dbSNP Location TDTb PDT G-PDT APL PDT G-PDT APL PDT G-PDT APL
rs5995288 Intron 1 0.82 F F F F F F F F F
rs739097 Intron 1 0.5 0.17 0.395 0.142 0.617 0.862 0.948 0.114 0.295 0.067
rs713839 Intron 3 F 0.067 0.191 0.11 0.452 0.558 0.596 0.043 0.151 0.094
rs713659 Intron 3 F 0.211 0.397 0.098 0.756 0.894 0.545 0.091 0.17 0.014
rs2071731 Intron 5 0.88 0.12 0.186 0.165 0.607 0.663 0.456 0.065 0.144 0.026
rs1002246 Intron 10 1 0.02 0.043 0.009 0.056 0.149 0.127 0.185 0.262 0.033
rs3752462 Intron 13 0.02 0.035 0.117 0.602 0.114 0.216 0.662 0.162 0.382 0.353
rs2239783 Intron 15 F 0.681 0.834 0.369 0.478 0.726 0.143 0.86 0.61 0.857
rs2009930 Intron 19 0.4 0.039 0.131 0.177 0.195 0.386 0.718 0.087 0.257 0.065
rs4821478 Intron 28 F 0.023 0.077 0.381 0.053 0.163 0.899 0.223 0.465 0.328
rs2269529 Exon 34 0.69 F F F F F F F F F
rs7078 Downstream 0.34 0.836 0.832 0.345 0.564 0.712 0.137 0.766 0.879 0.770
F, not genotyped.
aP-values have not been corrected for multiple testing.
bP-value o0.05 bolded.
Table 4 Parametric and non-parametric linkage analysis for MYH9
Parametric Non-parametric
dbSNP cM Base pair hLOD a LOD P-valuea
rs7078 35.008 35 007 860 0.018 0.083 0.01 0.4
rs4821478 35.02 35 020 059 0.033 0.109 0.02 0.4
rs2009930 35.029 35 029 252 0 0 0.07 0.7
rs2239783 35.035 35 035 074 0.174 0.213 0 0.5
rs3752462 35.04 35 040 129 0.108 0.205 0.12 0.2
rs1002246 35.045 35 044 605 1.578 0.694 2.26 0.0006
rs2071731 35.049 35 048 804 0 0 0 0.5
rs713659 35.059 35 058 638 0 0 0 0.5
rs713839 35.064 35 063 884 0 0.005 0 0.5
rs739097 35.076 35 076 025 0 0 0.01 0.6
aP-value o0.05 bolded.
Table 6 Association results for SDC2 and GDF6 on chromosome 8
All NHWa,b Simplex NHW Multiplex NHW
Gene dbSNP PDT G-PDT APL PDT G-PDT APL PDT G-PDT APL
(A) Non-Hispanic white populationc
SDC2 rs1042381 0.796 0.822 0.632 0.046 0.029 0.289 0.123 0.075 0.349
GDF6 rs2247792 0.804 0.223 0.149 0.804 0.223 0.147 0.631 0.013 0.244
GDF6 rs2440199 0.955 0.348 0.597 0.955 0.348 0.587 0.449 0.05 0.887
GDF6 rs2255182 0.582 0.036 0.764 0.582 0.036 0.763 0.679 0.019 0.678
All a,b Simplex Multiplex
Gene dbSNP PDT G-PDT APL PDT G-PDT APL PDT G-PDT APL
(B) Hispanic populationc
SDC2 rs2437772 0.522 0.168 0.819 0.336 0.487 0.716 1 0.035 0.915
SDC2 rs2437780 0.796 0.139 0.95 0.578 0.839 0.975 0.858 0.04 0.959
SDC2 rs2582831 0.655 0.89 0.147 1 0.793 0.04 0.564 0.668 0.878
SDC2 rs1984456 0.753 0.939 0.037 0.706 0.837 0.154 0.9 0.974 0.086
SDC2 rs2582846 0.274 0.594 0.058 0.132 0.281 0.036 0.715 0.804 0.548
aP-value o0.05 bolded.
bP-values have not been corrected for multiple testing.
cResults for SNPs with at least one test statistic Po0.05.
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ethnicity that resulted in the highest LOD score was
subjected to candidate gene analysis.
Eleven regions on six chromosomes with LOD scores
41.5 were identified in the non-Hispanic white families
(Table 2). The highest LOD score was found in chromoso-
mal region 22q12.2–12.3 and the total linkage area spans
over 20 cM. This region contains the MYH9 gene, which is
expressed in the developing palate and was found to be
associated with NSCLP in an Italian population.25,26
To further evaluate the role of MYH9 in NSCLP, 10
intragenic and flanking SNPs, which included six of the
SNPs genotyped in the Italian families, were interrogated in
our NSCLP sample.
Linkage was found between a single SNP, rs1002246,
in the MYH9 gene and our entire data set (Table 5),
consistent with the prior identification of this region in
our genome scan. PDT, G-PDT and APL analyses, all
identified this SNP in our entire NSCLP sample.
rs1002246 differs from the SNP found in the Italian NSCLP
sample (Table 5). rs1002246 is in intron 10 of the MYH9
gene but this is not in a region associated with intron–
exon splicing. Although intronic SNPs do not typically
alter protein structure, an association with intronic
variants has been reported for a number of complex
diseases.27,35 – 40 rs1002246 is located in a region of reduced
LD that can complicate identifying at-risk haplotypes
(Supplementary Table 3). In fact, we were unable to
identify a high-risk haplotype. Interestingly, rs3752462,
the SNP identified by the Italian group, was only margin-
ally significant in both data sets (Table 5). Our finding
of linkage by parametric and non-parametric analyses
and association strongly suggests that MYH9 may play
a causal role in NSCLP. Nevertheless, we cannot conclu-
sively exclude the possibility that another gene in the
22q12.2–12.3 chromosomal region is contributing to the
positive linkage and association. We are continuing to
evaluate this region.
This is the first NSCLP genomic scan to include an
African-American family. NSCLP is relatively rare in African
Americans with a birth prevalence of 1/2500, when
compared with 1/1400 in non-Hispanic whites and
Hispanics in Texas.3 Although earlier genome scans have
been performed on non-Hispanic white, Indian, Chinese
and Syrian populations, it is a rarity to find a large African-
American family with segregating NSCLP8 – 14 Using this
family, three chromosomal regions, 2p22, 3p26 and
8q21.3–24.12, were identified with LOD scores 41.5, of
which only 2p22 is new (Table 2).
The most significant linkage (LOD¼2.98) was to
8q21.3–24.12 region, the same region identified by the
meta-analysis, providing further support that this region
contains an NSCLP gene.15 SDC2 and GDF6 were found in
this region and, because of their known biological func-
tion, they were considered to be good candidate genes.
Nevertheless, linkage was not detected between either of
these genes and NSCLP in our data set. Marginal evidence
for association (0.01oPo0.05) was detected for SNPs in
both of these genes in the non-Hispanic white and
Hispanic samples. In SDC2, SNPs rs2437772 and
rs2437780 were both significant in the multiplex non-
Hispanic white data set using the G-PDT; however, neither
PDT nor APL detected a significant association. Therefore,
these results are marginal at best. Haplotype analysis
revealed altered transmission for two SDC2 haplotypes
(Po0.01). However, given the large number of haplotypes
tested, this does not provide strong evidence for a role of
SDC2 in NSCLP.
G-PDT analysis of SNPs in GDF6 found borderline
evidence for association in the non-Hispanic white data
set; PDT and APL tests were negative. rs2255182, in intron
1, was significant in the total non-Hispanic white data set
as well as when the data were stratified by family history
(Table 3A). In addition, rs2247792, 22.5 kb upstream of the
GDF6 gene, was associated in the multiplex non-Hispanic
white data set. Interestingly, analysis identified a signifi-
cant haplotype in the Hispanic data set, but not in the non-
Hispanic white sample (Table 7). Although association
analyses of the SNPs in SDC2 and GDF6 showed some
evidence for altered transmission, the level did not
correspond to the LOD score detected in this region. This
may be the result of linkage without an association. An
alternative explanation is that this region was identified in
an African-American family, and genes in this region do
not play a significant role in the non-Hispanic white and
Hispanic populations. NSCLP displays genetic heterogene-
ity with a variety of genes playing an etiologic role, and it is
likely that these genes vary with ethnicity.41 However,
because this region was also identified in other ethnicities,
additional testing is underway to interrogate this region in
the entire data set. Of particular interest is the Frizzled 6
(Fzd6) gene that is located in this region. Fzd6 is a Wnt
receptor whose expression is upregulated during osteo-
genic differentiation of mesenchymal stem cells.42 Fzd6
functions in the noncanonical Wnt pathway to decrease
the amount of binding of TCF/LEF and TCF–b-catenin to
target DNA.43 We have recently identified an association
between several Wnt genes and NSCLP,44 and studies are
Table 7 Overtransmitted haplotypes for SDC2 and GDF6
Gene dbSNP1 dbSNP2 Ethnicity P-value Haplotype
SDC2 rs2452993 rs7003874 NHW 0.01 1–2
SDC2 rs2452993 rs12156240 NHW 0.003 2–1
SDC2 rs2575738 rs2651472 H 0.04 2–1
SDC2 rs2575738 rs1836910 H 0.04 1–2
SDC2 rs2582846 rs12156240 H 0.016 2–1
GDF6 rs2440199 rs2514527 H 0.008 2–1
NHW, non-Hispanic white; H, Hispanic.
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underway to evaluate Fzd6 for association with NSCLP and
interaction with Wnt genes.
Regions 2p22 and 3p26 were also identified in the
African-American family; these are new avenues for
discovery of NSCLP genes. 2p22 is a novel chromosomal
region, whereas 3p26 was previously reported in a genome
scan of Chinese multiplex families.9 Further examination
of these regions needs to be undertaken to identify novel
NSCLP genes.
In addition to 22q12.2–q12.3 (which contains MYH9),
10 regions were identified in the non-Hispanic white
families with LOD scores greater than 1.5 but less
than 2. Four of these regions, 3p14.1–p13, 5p13.3,
7q36.2–q36.3 and 9q22.22–q22.32, were novel; however,
and there are no obvious candidate genes in two of these
regions (3p14.1–p13 and 5p13.3). The remaining six
regions have been reported earlier in genomic
scans.8 – 11,13 – 15
The 7q36.2–36.3 region is novel and contains sonic
hedgehog homolog (SHH) and engrailed homeobox 2
(EN2), two known NSCLP candidate genes. SHH plays a
critical role in the development and patterning of the
craniofacial processes that give rise to the developing lip
and palate.45 Mutations in the human SHH gene cause
holoprosencephaly-3, which can be associated with cleft
lip and palate (OMIM: #142945);46 SHH null mice can have
cleft palate.47 However, single-strand conformational poly-
morphism analysis of the SHH gene in NSCLP patients has
not identified any disease-causing mutations.48 EN2 plays a
role in the central nervous system development and has
also been implicated in autism spectrum disorders (OMIM:
#608636).49 Previous RFLP testing found no association
between the EN2 gene and NSCLP.50 Although no positive
findings have been found, these remain candidate genes of
interest.
Two regions on chromosome 9, 9q22.2–22.32 and
9q33.2–33.3, were identified in this genomic scan. The
9q22.2–22.32 region is novel and contains both the BarH-
like homeobox 1 (Barx1) and patched homolog 1 (PTCH1).
Mouse BARX1 is expressed in the first and second branchial
arches that form the craniofacial processes.51 The role of
Barx1 in NSCLP has not been evaluated. PTCH1, an SHH
receptor, in combination with BARX1, plays a role in mid-
face structure formation.52 Mutations in PTCH1 cause basal
cell nevus syndrome (BCNS; OMIM: #109400) and 5% of
BCNS patients have a cleft lip and palate.53 Interestingly,
forkhead box E1 (FOXE1), which plays a role in thyroid
morphogenesis, is located just outside this region in
9q22.33.54 The FOXE1 region has been identified in the
NSCLP genome scans.55 Mutations in FOXE1 cause the
Bamforth–Lazarus syndrome of which cleft palate is an
associated finding (OMIM: #241850). However, sequencing
of the FOXE1 gene in the NSCLP probands identified two
missense mutations, both of which were predicted to be
benign.56
There are some limitations to the study. NSCLP is
clearly heterogeneous, and among the non-Hispanic
white families, none have the potential to yield an LOD
score 41.6, making it difficult to obtain conclusive
evidence for linkage. The one family that can yield a
nearly significant LOD score is African American; this racial
group has a significantly lower risk of NSCLP than non-
Hispanic whites and Hispanics and very likely has a
different etiology. In addition, the sample for the associa-
tion studies is not large enough to detect SNPs with minor
effects. Nonetheless, we have identified new regions of
interest through linkage analyses as well as candidate genes
through our association studies, both of which warrant
further evaluation.
Here, we report six new regions (2p22, 3p13–14.1,
5p13.3, 7q36.2–36.3, 9q22.2–22.32 and 22q12.2–12.3)
that can be interrogated for NSCLP genes. We identified
eight regions that were previously implicated in other
genomic scans in a variety of populations. The strongest
linkages were found for the 8q21.3–24.12 and 22q12.2–
12.3 regions, with the MYH9 (chromosome 22) gene
exhibiting the strongest evidence for a causal role. This
gene should be further evaluated in other populations for
its possible role in NSCLP. The results of this study are
important as they provide additional regions to search for
new NSCLP genes and confirm the findings of earlier
genomic scans. Our findings also demonstrate that large
multiplex families with complex disorders can be success-
fully used in genome mapping strategies.
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